Clinical Trial Update: Study to Evaluate Initiation of Stalevo in Early Wearing-off [Phase 4]

View source ↗

Summary

A Phase 4 trial update reporting completion of a study evaluating initiation of Stalevo for early wearing-off in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED